1. Dramatic effect of early clopidogrel administration in reducing mortality and MACE rates in ACS patients. Data from the Swiss registry AMIS-Plus
- Author
-
Jean-Christophe, Stauffer, Jean-Jacques, Goy, Nicole, Duvoisin, Dragana, Radovanovic, Hans, Rickli, Paul, Erne, S, Christen, University of Zurich, AMIS group, Erne, P., Bertel, O., Eberli, F., Essig, M., Gutzwiller, F., Hunziker, P., Keller, PF., Maggiorini, M., Pedrazzini, G., Radovanovic, D., Rickli, H., Stauffer, JC., Urban, P., Windecker, S., Duvoisin, N., Bähler, C., Piket, J., Doukas, E., Hess, F., Simon, R., Hangartner, P., Lessing, P., Hufschmid, U., Grädel, C., Schönfelder, A., Schläpfer, H., Evéquoz, D., Vögele, A., Ryser, D., Jecker, R., Niedermaier, G., Droll, A., Hongler, T., Stäuble, S., Haarer, J., Schmid, H., Quartenoud, B., Bietenhard, K., Gaspoz, JM., Keller, P., Wojtyna, W., Oertli, B., Schönenberger, R., Waldburger, R., Schmidli, M., Weiss, E., Zender, H., Steffen, C., Hugi, A., Koltai, E., Luterbacher, T., Pagnamenta, A., Stettler, C., Repond, F., Widmer, F., Lusser, H., Polikar, R., Bassetti, S., Iselin, H., Giger, M., Egger, P., Kaeslin, T., Frey, R., Herren, T., Eichhorn, P., Neumeier, C., Flury, G., Grêt, A., Schöneneberger, R., Yoon, S., Loretan, P., Stoller, U., Veragut, U., Bächli, E., Weber, A., Federspiel, B., Weisskopf, M., Schmidt, D., Hellermann, J., Graber, M., Haller, A., Peter, M., Gasser, S., Siegrist, P., Fatio, R., Vogt, M., Ramsay, D., and Christen, S.
- Subjects
Adult ,Male ,Cardiac Catheterization ,Ticlopidine ,Time Factors ,Myocardial Infarction ,610 Medicine & health ,2700 General Medicine ,Electrocardiography ,Young Adult ,Confidence Intervals ,Odds Ratio ,Humans ,cardiovascular diseases ,Hospital Mortality ,Registries ,Acute Coronary Syndrome ,Aged ,Aged, 80 and over ,Aspirin ,10060 Epidemiology, Biostatistics and Prevention Institute (EBPI) ,Middle Aged ,Clopidogrel ,Logistic Models ,Multivariate Analysis ,Acute Coronary Syndrome/complications ,Acute Coronary Syndrome/drug therapy ,Aspirin/therapeutic use ,Drug Therapy, Combination ,Female ,Myocardial Infarction/etiology ,Platelet Aggregation Inhibitors/therapeutic use ,Switzerland ,Ticlopidine/analogs & derivatives ,Ticlopidine/therapeutic use ,Platelet Aggregation Inhibitors ,circulatory and respiratory physiology - Abstract
BACKGROUND: Patients who have acute coronary syndromes with or without ST-segment elevation have high rates of major vascular events. We evaluated the efficacy of early clopidogrel administration (300 mg) (
- Published
- 2012